Home Compliance Submitting Comments on the Inflation Reduction Act’s Medicare Drug Price Negotiation Program... ComplianceExpert OpinionFCANews Submitting Comments on the Inflation Reduction Act’s Medicare Drug Price Negotiation Program Guidance February 27, 2023 31 Share FacebookLinkedinTwitter Billion Photos | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance When Advocacy Turns Into Obstruction: A Cautionary Tale for Corporate Counsel Handling Gov’t Investigations Compliance March 2024 Developments Under President Biden’s Cybersecurity Executive Order, National Cybersecurity Strategy, and AI Executive Order Cyber Better Safe Than Sorry: OMB Releases Memorandum on Managing AI Risks in the Federal Government